Judge For Xarelto Bleeding Lawsuit Claims Advises On Case Selection For Bellweather Trials

   

Xarelto Bleeding Lawsuit Attorneys At Southern Med Law Evaluate Legal Claims Of Serious Internal Bleeding Episodes.

Xarelto-Lawsuits-Southern-Med-Law-AttorneyThe federal judge presiding over Xarelto bleeding lawsuit claims has developed the process for selecting Xarelto cases for discovery and bellwether trials. The federally filed Xarelto bleeding side-effects lawsuits against Bayer HealthCare and Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit, allege that the Xarelto blood thinner causes brain bleeds and internal bleeding episodes that result in hospitalization for transfusion or death. (In Re: Xarelto Products Liability Litigation, No. 2592)

U.S. District Judge Eldon Fallon said in a Case Management Order issued on November 20, that he developed the plan since attorneys for the plaintiffs and defendants were unable to resolve their disputes over how the cases should be selected. Under Judge Eldon’s plan, plaintiffs’ attorneys will select 10 cases and defendants’ attorneys will select 10 cases, and the remaining 20 cases will be selected randomly. Of the 40 Xarelto cases,

• 20 will originate from the U.S. District Court, Eastern District of Louisiana
• 4 will originate from the federal district in Mississippi
• 2 will originate from the federal district in Texas
• 7 will come from a federal district in any of seven states chosen by plaintiffs
• 7 cases will come from a federal district in any of seven states chosen by defendants

The CMO directed both parties to develop a plan before June 10, 2016 to select four cases, from the 40-case discovery pool, for bellwether trials. The parties are to submit their proposed case selection plan to the court by July 1, 2016. (In Re: Xarelto Products Liability Litigation, No. 2592)

“We are pleased with Judge Eldon’s decision to develop a case-selection plan so that the Xarelto litigation can continue to move forward,” says Dr. François Blaudeau, the founder of Southern Med Law.

As both an attorney and practicing physician, Southern Med Law’s Dr. François Blaudeau possesses a unique understanding of the medical and legal questions relating to Xarelto lawsuits. If you or a loved one experienced life-threatening internal bleeding or other complications allegedly associated with Xarelto, please contact the Firm as soon as possible to learn more about your legal rights. You can arrange for a free, no obligation Xarelto lawsuit review by calling Southern Med Law today, at 205-547-5525.

Xarelto is a prescription blood thinner approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of strokes, deep vein thrombosis, pulmonary embolism, and blood clots in patients who have undergone hip or knee replacement surgery. Xarelto is also approved to prevent blood clots in patients with atrial fibrillation. The FDA considers Xarelto a new generation anticoagulant compared to warfarin, a blood thinner that has been sold since 1954. Xarelto, however, does not have an approved antidote to treat internal bleeding whereas warfarin uses vitamin K as an antidote for any bleeding side effects, according to the FDA.
[fda.gov/Drugs/NewsEvents/ucm405148.htm, July 17, 2014]
[fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, June 2015

All federally filed Xarelto bleeding side-effects lawsuit claims were centralized in December 2014 in the U.S. District Court, Eastern District of Louisiana for coordinated pretrial proceedings. The potential cases selected for bellwether trials will go through a discovery process in which plaintiffs and defendants exchange evidence and information about the claims. Bellwether jury trials serve as “test trials” and provide insight into how similar Xarelto claims could be decided. Judge Fallon has scheduled the first bellwether trial for February 6, 2017, and the next three trials for March 13, 2017, April 24, 2017 and May 30, 2017. (In Re: Xarelto Products Liability Litigation, No. 2592)

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525

Fax: 205-547-5526
francois@southernmedlaw.com
http://www.southernmedlaw.com

This entry was posted in Southern Med Law | Article. Bookmark the permalink.